OUR MEDICINES

Our broad portfolio consists of 16 prescription medicines. Unfortunately, we cannot provide comprehensive information about our medicines on this website, in compliance with regulations.

However, if you are a healthcare professional, you can find more comprehensive, local information selecting the country of your residence in the drop-down menu below.

Our global medicines portfolio:

Trademark Generic
Vocabria cabotegravir
Rukobia fostemsavir
Cabenuva 
cabotegravir and rilpivirine
Dovato dolutegravir and lamivudine
Juluca
dolutegravir and rilpivirine
Triumeq
dolutegravir/ abacavir/ lamivudine
Tivicay
dolutegravir
Selzentry/ Celsentri
maraviroc
Epzicom/ Kivexa
abacavir/ lamivudine
Ziagen
abacavir
Trizivir
abacavir/ lamivudine/ zidovudine
Combivir
lamivudine/ zidovudine
Epivir/ 3TC
lamivudine
Retrovir/ AZT
zidovudine
Lexiva/ Telzir
fosamprenavir
Viracept
nelfinavir

This medicine is subject to additional monitoring. If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard. By reporting side effects, you can help provide more information on the safety of this medicine.

Our stories